Has Dina Bowen received payments from drug or device companies?

Yes. Drug and device makers reported $2,417 in general payments to Dina Bowen across 138 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dina Bowen did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dina Bowen come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dina Bowen

Pediatrics · Yukon, OKNPI 1336188937

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Among pediatrics clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,417in general payments, 2019–2025

Across 138 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Corium, LLC$537
Tris Pharma Inc$510
Supernus Pharmaceuticals, Inc.$296
Takeda Pharmaceuticals U.S.A., Inc.$219
GSK$130
Pfizer$108
plus $617 from 13 others

What the payments were for

Food & beverage$2,417100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Corium, LLC	24	$537
Tris Pharma Inc	30	$510
Supernus Pharmaceuticals, Inc.	21	$296
Takeda Pharmaceuticals U.S.A., Inc.	16	$219
GSK	7	$130
Pfizer	5	$108
Adlon Therapeutics L.p.	6	$106
Sobi, Inc	5	$83
Kowa Pharmaceuticals America, Inc.	3	$71
Merck	4	$62
Ironshore Pharmaceuticals Inc.	3	$55
Kaleo, Inc.	3	$55
Collegium Pharmaceutical, Inc.	2	$40
AstraZeneca	2	$36
Sanofi Pasteur Inc.	2	$32
Neos Therapeutics, LP	2	$29
Cranial Technologies, Inc	1	$19
Biogen	1	$16
Seqirus USA Inc	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Azstarys$124

How this compares

$2,417 in reported general payments places this provider in the 90th percentile of 568 pediatrics providers in Oklahoma.

See all pediatrics providers in Oklahoma →

Other pediatrics in Yukon

Martha ArambulaYukon$3K
Trinity LovelessYukon$3K
Sarah BratcherYukon$2K
Stanley GroggTulsa$24K
Scott MelsonOklahoma City$11K
Angela ConradTulsa$6K
Todd ColemanTulsa$5K
Julie MayOklahoma City$5K
Patrick DaleyTulsa$5K
Laurie OrmeEdmond$5K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →